Rate My Professor Jo Martin

Professor Jo Martin is Professor of Pathology at Queen Mary University of London in the Faculty of Medicine and Dentistry, where she also serves as Deputy Vice Principal (Health) and Interim Director of the Institute of Health Sciences Education. She qualified in medicine from Cambridge University for preclinical studies and the London Hospital Medical College for clinical training, obtaining degrees including MA, MB BS, PhD from the University of London focused on the cellular pathology of motor neurone disease, and MA in Leadership from the Kings Fund programme. FRCPath qualified, her clinical specialist expertise encompasses renal histopathology and the pathology of gastrointestinal motility disorders, including neuromuscular disease of the gut. She has authored over 130 peer-reviewed publications in high-impact journals such as those in the Nature group and Science, contributing significantly to advancements in pathology.

Professor Martin's distinguished career includes leadership as National Clinical Director of Pathology for NHS England from 2013 to 2016, President of the Royal College of Pathologists from 2017 to 2020, and current National Specialty Advisor for Pathology for NHS England and Improvement, chairing the national Pathology Stakeholder Board and Pathology Workforce Board. She served as a director on the Board of Barts Health NHS Trust for five years, as Medical Director and Chief Medical Officer, leading education and training for over 17,500 staff, and as executive host lead for NIHR CLRN North Thames and CLAHRC. A co-founder of Biomoti, a drug delivery development company, she developed an award-winning eCPD app delivering over 50,000 modules to healthcare staff and leads the Pathology Portal, a multi-professional international digital adaptive learning programme for the Royal College of Pathologists and Health Education England, which won the Outstanding Innovation Award at the Healthcare Honours 2023. Awarded a CBE in 2022 for services to the NHS and medical education, she has chaired the Motor Neurone Disease Association Research Advisory Board and provided volunteer medical support during the COVID-19 vaccine programme.